| Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients |
| Author(s): Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 |
| Affiliations(s): 1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada |
| Publication(s): Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Rheumatology
2017 |
|
L:
A: |
English
Database Study |
|
 |
| |
| |
| Impact of adalimumab’s patient support program on clinical outcomes
in inflammatory bowel diseases: Results from the COMPANION study |
| Author(s): Marshall JK1, Narula N1, Millson B2, Charland K2, Sung M2, Gaetano T3, McHugh K3, Latour M3, Laliberté MC3 |
| Affiliations(s): |
| Publication(s): European Crohn’s and Colitis Organization 2017 Conference, February 15-18, Barcelona, Spain |
| Document Type(s): Poster |
| Countries: Canada |
C:
Y: |
Gastrointestinal disorders
2017 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Prevalence of Primary Biliary Cholangitis in Canada: First National Study |
| Author(s): Yoshida EM1, Thiele S2, Fischer A2, Mason A3, Shah H4, Peltekian K5, Hux M2, Borrelli R2 |
| Affiliations(s): 1 Division of Gastroenterology, University of British Columbia 2 QuintilesIMS 3 University of Alberta 4 University of Toronto 5 Dalhousie University |
| Publication(s): CANADIAN DIGESTIVE DISEASES 2017 CONFERENCE, MARCH 3-6, BANFF, Canada |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Miscellaneous
2017 |
|
L:
A: |
English
Retrospective cohort analysis |
|
|
| |
| |
| Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients: Three-Year Results from the COMPANION Study in Gastroenterology Patients |
| Author(s): Marshall JK1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 |
| Affiliations(s): 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 AbbVie Corporation, St. Laurent, Quebec, Canada |
| Publication(s): Canadian Digestive Diseases Week 2017 Annual Scientific Conference, March 3-6, Banff, Canada |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Gastrointestinal disorders
2017 |
|
L:
A: |
English
Database Study |
|
|
| |
| |
| UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY |
| Author(s): Lapierre M, Fraelic A |
| Affiliations(s): IMS Health, Kirkland, QC, Canada, IMS Health, Canada, Kanata, QC, Canada |
Publication(s): ISPOR 21st, May 21-25 - 2016 Washington DC USA
Value in Health, 2016, 19(3): A162 |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| REAL-WORLD COMPARISON OF METASTATIC MELANOMA TREATMENTS BETWEEN ACADEMIC AND COMMUNITY HOSPITALS IN CANADA: A RETROSPECTIVE STUDY |
| Author(s): Lapierre M |
| Affiliations(s): IMS Health, Kirkland, QC, Canada |
| Publication(s): ISPOR 21st, May 21-25 - 2016 Washingtown DC USA |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| CHARACTERIZATION OF STATIN EFFECTIVENESS USING REAL-WORLD DATA IN A CANADIAN POPULATION |
| Author(s): Shojaie S, McCurdy S, Thiele S, Ching Chau L, Martin L, Charland K, Dobson-Belaire W, Duclos M, Borrelli R |
| Affiliations(s): IMS Health Brogan., Mississauga, ON, Canada, IMS health Brogan, Kirkland, QC, Canada, IMS Health Brogan, Mississauga, ON, Canada |
| Publication(s): ISPOR 21st, May 2016, Washington, DC USA |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Second-line drug regimens in metastatic melanoma patients based on BRAF mutation status: A Canadian real-world retrospective study |
| Author(s): Bremner S1, Lapierre M2, Fraelic A1, Stewart D1 |
| Affiliations(s): 1 IMS Health, Kanata, ON, Canada 2 IMS Health, Kirkland, QC, Canada |
| Publication(s): 2016 ASCO Annual Meeting |
| Document Type(s): Abstract |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| No Substitution: Not just for Physicians Anymore |
| Author(s): Gillman A, Fischer A |
| Affiliations(s): QuintilesIMS, Toronto, Canada |
| Publication(s): 2016 Annual CAPT Conference |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Miscellaneous
2016 |
|
L:
A: |
English
Review |
|
|
| |
| |
| pCPA/CDR/pCODR Changes and Impact to Market Access in Canada |
| Author(s): Millson B, Zhang Y |
| Affiliations(s): IMS Brogan, A unit of IMS Health, Kirkland, QC, Canada |
| Publication(s): 2016 ISPOR Conference |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Pricing and reimbursement
2016 |
|
L:
A: |
English
Database Study |
|
|
| |
| |
 1 of 8 
|
